England’s drug price regulator will have to reconsider its decision to rule out using Eli Lilly’s Alzheimer’s drug in the state-run National Health Service, following a successful appeal by the US drugmaker https://t.co/fWXon8Qsap ...

It was many years back one summer. It was very very hot summer the March. I was having a long journey of 9 months. I really enjoyed this 9 months journey.Then suddenly that day I felt little cool. Why. Because there was a heavy rain one day before in the west coast of India.There was a lot of wind was coming and I was really enjoying. Then suddenly there was a push that I came out in this world. That was the day I was born and then I went to many many roller coaster in the life.One instant I know very sure ...

Hello everyone. Can I ask you a question. Have you ever had a bad hair day. What about a no hair day.Well, let me tell you about a time when I was 29 years old and a mother of four small children. I received um news, three small words that no one ever really wants to hear and that is you have cancer. Yep.This is me with my brother. You probably don't recognize me because I have hair now, but in that moment, my world went into a tail spin. I was thrust into tons of appointments, decisions, and treatments.But ...

Core Viewpoint - Amneal Pharmaceuticals, Inc. (AMRX) has shown positive stock performance since receiving a Buy rating a year ago, indicating a successful investment call [1]. Group 1: Company Overview - Amneal Pharmaceuticals, Inc. is highlighted as a stock that has performed well, with a significant increase in value since the last analysis [1]. Group 2: Analyst Background - The analysis is conducted by a biotech consultant with over 5 years of experience in the biotech, healthcare, and pharma sectors, having prepared detailed reports on more than 1,000 companies [1]. - The investing group Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts, buy and sell ratings, product sales forecasts, and financial analyses [1].

Patients are unhappy. Can AI help? https://t.co/vhLoDWJ9Oq ...

RT Wall Street Mav (@WallStreetMav)"Canada has free healthcare"Wait times ...Surgery : 284 days or longerKill you : no waitI guess they did the financial math and it is cheaper to offer to kill their citizens. So they prioritized that.Then they made it easier for 3rd world migrants to come and replace them.This is the end result of socialism. ...

RT Yipeng Ge 葛义朋 (@yipengGe)Israel has been attacking hospitals and health facilities in Iran. Their policy and practice of targeting and destroying healthcare in Palestine as a method of unlawful and immoral warfare is being exported and used on Iran. ...

Very good afternoon to you all. I want to start with really telling you a little bit about what I've learned in healthcare. In hospitals, chaos is not unusual.Suddenly, a patient is wheeled into the emergency room. A life changes in seconds. Doctors make decisions under pressure and families wait hoping against hope.In healthcare, chaos is not an exception. It's the environment. And yet inside this chaos, a surgeon still finds precision, a nurse still finds calm, and healing still finds a way.What I've lear ...

Group 1 - The article promotes a weekly newsletter focused on stocks in the biotech, pharma, and healthcare industries, highlighting key trends and catalysts that influence market valuations [1] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group, which caters to both novice and experienced investors [1] - The investing group provides insights such as buy and sell ratings, product sales forecasts for major pharmaceutical companies, integrated financial statements, discounted cash flow analysis, and market-specific analyses [1]

Economic Overview - Global GDP growth is projected at 2.7–2.8% for 2026, below pre-COVID averages, with advanced economies growing modestly and Asia-Pacific, particularly India, showing resilience with a growth rate of approximately 6.6% [1] - The IMF forecasts advanced economies to grow around 1.8%, while emerging markets and developing economies are expected to exceed 4% growth in 2026, indicating a widening economic gap [2] Market Polarization - Equity markets are experiencing polarization, driven by significant capital flows into megatrends such as AI investment, clean energy, and healthcare [3] - Artificial intelligence investment is identified as the primary driver of market polarization in 2026, with major technology companies significantly increasing capital expenditures [4] AI Investment - Major technology firms, including Amazon, Alphabet, Microsoft, and Meta, are projected to spend approximately $650 billion on AI-related infrastructure in 2026, marking a 67% increase from 2025 [5] - Semiconductor foundries are expanding, with Taiwan Semiconductor (TSM) raising its 2026 capex target to $52-$56 billion, reflecting strong demand for AI [7] Sector Analysis AI & Technology Infrastructure - Companies involved in AI infrastructure, such as NVIDIA (NVDA) and Vertiv Holdings (VRT), are positioned to benefit from the AI capital-expenditure cycle, with NVDA expected to report earnings growth of 57.7% in fiscal 2027 and VRT projected to grow earnings by 46.9% in 2026 [9] Renewable Energy & Battery Materials - The energy transition is accelerating, with Albemarle (ALB) expected to benefit from rising lithium demand linked to electric vehicles and stationary storage, projecting an earnings growth of 855.7% in 2026 [10] Healthcare & Biotech - The healthcare sector is supported by demographic trends and technological innovations, with Axsome Therapeutics (AXSM) expected to achieve 109% earnings growth in 2026, driven by advancements in AI-assisted drug discovery [11]